TTRX · Turn Therapeutics Inc
United States · RS rating 79 · As of 2026-11-03
| Price | 9.51 USD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 79 / 18 / 68 / 94 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 32 / 55 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +38.0% |
| Market cap (USD) | $99.8M |